Intelligence Β· Patent portfolio
Kura Oncology Patents
Full USPTO pharma patent portfolio for Kura Oncology β grant dates, expiration, and drug cross-links.
- Patents
- 132
- Expiring β€24m
- 1
Quick answer
Kura Oncology has 132 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months β use filters for patent-cliff planning.
-
US 10426767
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10335404
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 10301317
Inhibitors of ERK and methods of use
granted -
US 10292979
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 10285913
Dental polymerizable composition, dental temporary cement, dental filling material, denture liner, and dental tissue conditioner
granted -
US 10280120
Zirconia composition, zirconia pre-sintered body and zirconia sintered body, and dental product
granted -
US 10273189
Zirconia composition, zirconia pre-sintered body and zirconia sintered body, and dental product
granted -
US 10231905
Dental curable composition
granted -
US 10172695
Method for manufacturing dental mill blank
granted -
US 10137121
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10123947
Dental cement
granted -
US 10071028
Dental adhesive
granted -
US 10022364
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 9993394
Dental restorative composition
granted -
US 9962319
One-component-type dentinal tubule sealant
granted -
US 9956215
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 9951078
Inhibitors of ERK and methods of use
granted -
US 9889070
Curable composition
granted -
US 9890487
Liquid-retaining sheet and facial mask
granted -
US 9867846
Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis
granted -
US 9855196
Dental curable composition and dental flowable composite resin
granted -
US 9844495
Self-adhesive dental composite resin
granted -
US 9827268
Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials
granted -
US 9789031
Dental adhesive kit
granted -
US 9707221
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 9700491
One-part dental adhesive
granted -
US 9675527
Dental color tone adjustment material kit
granted -
US 9624228
Inhibitors of ERK and methods of use
granted -
US 9526675
Dentinal tubule sealing material
granted -
US 9427381
Dental curable composition, and method for producing same
granted -
US 9415068
Method for inhibiting dentinal hypersensitivity
granted -
US 9333148
Polymerizable composition and dental material
granted -
US 9271901
One-part dental adhesive composition
granted -
US 9174411
Laminated sheet and process for producing the same
granted -
US 9125802
Dental curable composition
granted -
US 9089482
Dental mill blank
granted -
US 8932060
Dental treatment method
granted -
US 8912172
Skin external preparation containing triterpenic acid
granted -
US 8906151
Calcium phosphate composition and process for producing the same
granted -
US 8895680
Redox curing-type nonaqueous curable composition
granted -
US 8703840
Dental adhesive material kit
granted -
US 8609235
Porous ceramic material and method of producing the same
granted -
US 8563618
Skin external preparation having excellent stability
granted -
US 8552088
Cement for dental applications
granted -
US 8545225
Redox-curing type composition
granted -
US 8476338
Dental curable composition and composite resin using the same
granted -
US 8329845
Divided redox-curing type composition
granted -
US 8147807
Oral composition for dental purposes
granted
Frequently asked questions
How many patents does Kura Oncology have?
132 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Kura Oncology patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory